SEC Form 4/A · accession 0001437749-18-013122
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John S. Runyan
Director
Period of report
Jun 29, 2018
Accepted (ET)
Jul 9, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1,F2 | $0.43 | Jun 29, 2018 | A | 43,605 | A | Jun 29, 2018 | Jun 29, 2028 | Common stock | 43,605 | 1,161,665 | D |
Explanation of responses
- F1This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the three months ended June 30, 2018, pursuant to the Issuer's 2018 Equity Incentive Plan.
- F2As amended. See Remarks, below.
Remarks
This Form 4 is being amended to correct a clerical error in the number of derivative securities beneficially owned following the reported transaction, as originally reported in Table II, Column 9. The corrected number was reduced by 18,382 shares as compared with the originally reported number.